Advertisement

Topics

Amgen loses appeal over Epogen biosimilar

04:27 EDT 11 Aug 2017 | BioPharmaDive

The biotech had sought to compel Pfizer to disclose more information about its copycat biologic, which was unexpectedly rejected earlier this summer.

Original Article: Amgen loses appeal over Epogen biosimilar

NEXT ARTICLE

More From BioPortfolio on "Amgen loses appeal over Epogen biosimilar"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...